Latest Quarter
2026-04-07
Concord Healthcare Grp Co Ltd (2453.HK)
Revenue
$201M
Net Income
-$177M
Operating Margin
-59.9%
Free Cash Flow
-$500M
Debt / Assets
67.8%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2026-04-07 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 200,903,000 | 200,903,000 | 100,451,500 | 169,317,000 |
| Cost of Revenue | 200,520,000 | 200,520,000 | 100,260,000 | 202,063,000 |
| Gross Profit | 383,000 | 383,000 | 191,500 | -32,746,000 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 107,125,000 | 107,125,000 | 53,562,500 | 166,358,000 |
| Operating Expenses | 120,743,000 | 120,743,000 | 60,371,500 | 183,414,000 |
| Operating Income | -120,360,000 | -120,360,000 | -60,180,000 | -216,160,000 |
| Interest Expense | 0 | 66,328,998 | 0 | 56,035,000 |
| Income Before Tax | -201,992,000 | -201,992,000 | -100,996,000 | -281,327,000 |
| Income Tax Expense | 1,971,000 | 1,971,000 | 985,500 | 1,472,000 |
| Net Income | -176,598,000 | -176,598,000 | -88,299,000 | -261,346,998 |
| Per Share | ||||
| EPS | -0.24 | -0.24 | -0.12 | -0.36 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Revenue | 388,305,000 | 538,650,000 |
| Cost of Revenue | 455,553,000 | 603,739,000 |
| Gross Profit | -67,248,000 | -65,089,000 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 259,357,000 | 252,965,000 |
| Operating Expenses | 330,299,000 | 288,577,000 |
| Operating Income | -371,207,000 | -353,666,000 |
| Interest Expense | 109,267,000 | 108,006,000 |
| Income Before Tax | -485,849,000 | -432,592,000 |
| Income Tax Expense | -1,031,000 | -6,198,000 |
| Net Income | -443,223,000 | -373,090,000 |
| Per Share | ||
| EPS | -0.62 | -0.52 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 204,544,000 | 40,577,000 |
| Short Term Investments | 132,575,000 | 8,656,000 |
| Net Receivables | 193,051,000 | 75,984,000 |
| Inventory | 33,441,000 | 40,347,000 |
| Total Current Assets | 713,620,000 | 359,801,000 |
| Property Plant Equipment | 3,930,349,000 | 3,448,393,000 |
| Goodwill and Intangibles | 826,372,000 | 851,667,000 |
| Total Assets | 5,906,562,000 | 5,236,396,000 |
| Liabilities | ||
| Account Payables | 112,146,000 | 127,069,000 |
| Short Term Debt | 402,617,000 | 548,044,000 |
| Total Current Liabilities | 1,135,864,000 | 1,204,517,000 |
| Long Term Debt | 2,807,302,000 | 2,094,604,000 |
| Total Liabilities | 4,005,752,000 | 3,367,211,000 |
| Shareholders Equity | ||
| Retained Earnings | -3,746,678,000 | -3,303,455,000 |
| Total Shareholders Equity | 1,647,897,000 | 1,599,089,000 |
| Balance Sheet (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 204,544,000 | 40,577,000 |
| Short Term Investments | 132,575,000 | 8,656,000 |
| Net Receivables | 193,051,000 | 75,984,000 |
| Inventory | 33,441,000 | 40,347,000 |
| Total Current Assets | 713,620,000 | 359,801,000 |
| Property Plant Equipment | 3,930,349,000 | 3,448,393,000 |
| Goodwill and Intangibles | 826,372,000 | 851,667,000 |
| Total Assets | 5,906,562,000 | 5,236,396,000 |
| Liabilities | ||
| Account Payables | 112,146,000 | 127,069,000 |
| Short Term Debt | 402,617,000 | 548,044,000 |
| Total Current Liabilities | 1,135,864,000 | 1,204,517,000 |
| Long Term Debt | 2,807,302,000 | 2,094,604,000 |
| Total Liabilities | 4,005,752,000 | 3,367,211,000 |
| Shareholders Equity | ||
| Retained Earnings | -3,746,678,000 | -3,303,455,000 |
| Total Shareholders Equity | 1,647,897,000 | 1,599,089,000 |
| Cash Flow Statement (Quarterly) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -443,223,000 | -432,592,000 |
| Depreciation & Amortization | 114,062,000 | 152,007,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | 70,590,000 | 403,706,000 |
| Operating Cash Flow | -185,964,000 | 201,853,000 |
| Investing Activities | ||
| Capital Expenditure | -314,156,000 | -183,748,000 |
| Investments | 0 | -177,931,000 |
| Investing Cash Flow | -668,087,000 | -182,341,000 |
| Financing Activities | ||
| Debt Repayment | 701,456,000 | -19,709,000 |
| Common Stock Issued/Repurchased | 517,886,000 | 300,000,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,018,018,000 | -105,431,000 |
| Summary | ||
| Free Cash Flow | -500,120,000 | 18,105,000 |
| Net Change in Cash | 163,967,000 | -85,919,000 |
| Cash Flow Statement (Annual) | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Activities | ||
| Net Income | -443,223,000 | -432,592,000 |
| Depreciation & Amortization | 114,062,000 | 152,007,000 |
| Stock Based Compensation | 0 | 0 |
| Change in Working Capital | 70,590,000 | 403,706,000 |
| Operating Cash Flow | -185,964,000 | 201,853,000 |
| Investing Activities | ||
| Capital Expenditure | -314,156,000 | -183,748,000 |
| Investments | 0 | -177,931,000 |
| Investing Cash Flow | -668,087,000 | -182,341,000 |
| Financing Activities | ||
| Debt Repayment | 701,456,000 | -19,709,000 |
| Common Stock Issued/Repurchased | 517,886,000 | 300,000,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,018,018,000 | -105,431,000 |
| Summary | ||
| Free Cash Flow | -500,120,000 | 18,105,000 |
| Net Change in Cash | 163,967,000 | -85,919,000 |